Marinus Pharmaceuticals Secures $20,000,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cbeb0c98-b936-4c7f-b504-cdd626200ba3&Preview=1 -
Date
4/10/2009 -
Company Name
Marinus Pharmaceuticals -
Mailing Address
21 Business Park Drive Branford, CT 06405 -
Company Description
Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus is located in Branford, Connecticut and its investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. -
Website
http://www.marinuspharma.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The funding will advance the Company’s ganaxolone development program for use as a novel adjunctive agent for the treatment of refractory partial seizures and to explore proof of concept studies in psychiatric indications. -
M&A Terms
-
Venture Investor
Canaan Partners -
Venture Investor
Domain Associates -
Venture Investor
Sofinnova Ventures -
Venture Investor
Foundation Medical Partners
